home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

HIV Nef Damages Antibody Responses

  January, 31 2006 8:23
your information resource in human molecular genetics
A new mechanism by which human immunodeficiency virus (HIV) cripples immune responses in virus-infected AIDS patients is reported in the March issue of Nature Immunology. HIV Nef protein blocks critical signaling pathways in B cells, disrupting their ability to make effective neutralizing antibodies to the virus.

Andrea Cerutti and colleagues show Nef protein released by infected cells can prevent B cells from undergoing a full maturation process called antibody class switch recombination (CSR). CSR tailors antibody responses to best counter the offending pathogen e.g. CSR is required to make antibodies that can cross mucosal borders to inhibit viruses present in body secretions. Nef alone was sufficient to disrupt CSR by activating natural inhibitors of this process in B cells. Although B cells could still secrete an immature type of antibody, called IgM, these antibodies are not nearly as effective at clearing pathogens throughout the body and especially at mucosal surfaces, which are the primary sites of viral entry.

These data help to explain why anti-viral antibody immune responses are so poor, even at early times after infection when patients T cell counts are still high enough to trigger antibody production. Countering this Nef-induced inhibition might help to stem HIV early in infection.

Author contact:

Andrea Cerutti (Weill Medical College of Cornell University, NY, USA)
Email: acerutti@med.cornell.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.